SCHEMBL19617682

SCHEMBL19617682

C=Cc1cccc(S(=O)(=O)Nc2cscn2)c1

nearest known ligand 0.46

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 10/20 0.46
SCN5A Q14524 9/20 0.46
SCN1A P35498 9/20 0.46
SCN8A Q9UQD0 9/20 0.46
SLC22A12 Q96S37 1/20 0.42
MCL1 Q07820 1/20 0.40
NR1I2 O75469 1/20 0.39
CYP2C9 P11712 1/20 0.39
SCN1B Q07699 1/20 0.39
SCN2A Q99250 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16720161 0.80 SCN1A (0.48) SCN9ASCN5ASCN1ASCN8ASLC22A12
SCHEMBL22634311 0.80 KMT2A (0.54) SCN9ASCN5ASCN1ASCN8A
SCHEMBL1093964 0.78 SCN1A (0.54) SCN9ASCN5ASCN1ASCN8ANR1I2
SCHEMBL1095602 0.76 GLO1 (0.53) SCN9ASCN5ASCN1ASCN8ASLC22A12
Formic Acid SCHEMBL19616986 0.75 SCN1A (0.49) SCN9ASCN5ASCN1ASCN8ANR1I2
SCHEMBL3477271 0.72 SLC40A1 (0.50) SCN9ASCN5ASCN1ASCN8A
SCHEMBL11704625 0.70 SMN1; SMN2 (0.56) SCN9ASCN5ASCN1ASCN8ACYP2C9
SCHEMBL29669168 0.69 SCN1A (0.57) SCN9ASCN5ASCN1ASCN8ASLC22A12
SCHEMBL19613699 0.69 SCN1A (0.57) SCN9ASCN5ASCN1ASCN8ASLC22A12
SCHEMBL19613818 0.69 SCN1A (0.58) SCN9ASCN5ASCN1ASCN8ASLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109526219-A Benzsulfamide and its purposes as therapeutic agent 泽农医药公司 2019-03-26 CN claimed
EP-3458449-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Xenon Pharmaceuticals Inc. (CA) 2019-03-27 EP disclosed
CN-109526219-A Benzsulfamide and its purposes as therapeutic agent 泽农医药公司 2019-03-26 CN disclosed
WO-2017201468-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2017-11-23 WO disclosed